Corrigendum: IRB Approval Number Correction. Cardiac Dysfunction in Association with Increased Inflammatory Markers in Primary Aldosteronism

Article information

Endocrinol Metab. 2020;35(3):671-671
Publication date (electronic) : 2020 July 30
doi : https://doi.org/10.3803/EnM.2020.305
1Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea
2Institute of Evidence Based Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea
3Division of Cardiology, Severance Cardiovascular Hospital and Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul, Korea
4Department of Radiology, Yonsei University College of Medicine, Seoul, Korea
5Institute of Lifestyle Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea
6Department of Internal Medicine, Severance Hospital, Endocrine Research Institute, Yonsei University College of Medicine, Seoul, Korea
Corresponding author: Yumie Rhee Department of Internal Medicine, Severance Hospital, Endocrine Research Institute, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea Tel: +82-2-2228-1973, Fax:+82-2-393-6884, E-mail: yumie@yuhs.ac

Endocrinol Metab 2016;31:567-76

https://doi.org/10.3803/EnM.2016.31.4.567

In our recently published article, there were some wrong contents in the Methods section, which should be properly revised as follows:

The protocol was approved by the Ethics Committee of the Yonsei University College of Medicine (IRB No. 4-2012-0544).

We would like to apologize for any inconvenience or misunderstanding.

Article information Continued